1McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance[ J ]. FEMS Mierobiol Rev, 2002, 26( 1 ) :91-107.
2Arya SC. Antiviral therapy for neurological manifestations of enterovirus 71 infection[ J]. Clin Infect Dis,2000, 30(6) :988.
3Rawlinson WD. Antiviral agents for influenza, hepatitis C and herpesvirus, enterovirus and rhinovirus infections [ J ]. Med J Aust, 2001, 175(2) :112-116.
4Foo DG, Ang RX, Alonso S, et al. Identification of immunodominant VP1 linear epitope of enterovirus 71 ( EVT1 ) using synthetic peptidcs for detecting human anti-EV71 IgG antibodies in Western blots[J]. Clin Microbiol Infect,2008, 14(3) :286-288.
5Chen HL, Huang JY, Chu TW,et al. Expression of VP1 protein in the milk of transgenic mice : A potential oral vaccine protects against enterovirus 71 infection[J]. Vaccine,2008,26(23) :2882-2889.
6Tung WS, Bakar SA, Sekawi Z, et al. DNA vaccine constructs against enteruvirus 71 elicit immune response in mice[ J ]. Genet Vaccines Ther,2007, 5:6.
